Thyroid cancer is the most common endocrine malignancy and female hormones can contribute to modulate cellular proliferation and cell cycle progression through receptor-mediated transcriptional mechanisms [[37], [38], [39]]; moreover, previous studies reported the expression of progesterone and estrogenic receptors in thyroid cancer in various degrees [40]. The gene discussed is ESR1; the disease is thyroid gland carcinoma.